PI3K in cancer-stroma interactions: bad in seed and ugly in soil. (Q38124762)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

title

PI3K in cancer-stroma interactions: bad in seed and ugly in soil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

2

E Ciraolo

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

29 August 2017

3

I Franco

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

29 August 2017

4

A Ghigo

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

29 August 2017

5

M Martini

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

29 August 2017

language of work or name

English

0 references

publication date

29 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

3083-3090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23893246%20AND%20SRC:MED&resulttype=core&format=json

Structure and function of phosphoinositide 3-kinases.

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The phosphoinositide 3-kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The emerging mechanisms of isoform-specific PI3K signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Targeting the PI3K signaling pathway in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Present and future of PI3K pathway inhibition in cancer: perspectives and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphatidylinositol 3-kinase isoforms as novel drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

AKT/PKB signaling mechanisms in cancer and chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The dual PI3K and mTOR inhibitor NVP-BEZ235 exhibits anti-proliferative activity and overcomes bortezomib resistance in mantle cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PTEN loss in the continuum of common cancers, rare syndromes and mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Class I PI3K in oncogenic cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Interphase FISH analysis of PTEN in histologic sections shows genomic deletions in 68% of primary prostate cancer and 23% of high-grade prostatic intra-epithelial neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Functional analysis of PIK3CA gene mutations in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Genetic alterations of phosphoinositide 3-kinase subunit genes in human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Cancer-specific mutations in phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PIK3CA mutations in breast cancer are associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

A specific function for phosphatidylinositol 3-kinase alpha (p85alpha-p110alpha) in cell survival and for phosphatidylinositol 3-kinase beta (p85alpha-p110beta) in de novo DNA synthesis of human colon carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Key role of phosphoinositide 3-kinase class IB in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PIKing the right isoform: the emergent role of the p110beta subunit in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphoinositide 3-kinase p110beta activity: key role in metabolism and mammary gland cancer but not development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

A biochemical mechanism for the oncogenic potential of the p110β catalytic subunit of phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Local treatment of metastatic cancer--killing the seed or disturbing the soil?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The tumor microenvironment and its contribution to tumor evolution toward metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The immune contexture in human tumours: impact on clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3K inhibition in inflammation: Toward tailored therapies for specific diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3K signalling in B- and T-lymphocytes: new developments and therapeutic advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Leukemic challenge unmasks a requirement for PI3Kdelta in NK cell-mediated tumor surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3Kδ is essential for tumor clearance mediated by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Does the PI3K pathway promote or antagonize regulatory T cell development and function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Cancer immunotherapy via dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Immunotherapy with PI3K inhibitor and Toll-like receptor agonist induces IFN-γ+IL-17+ polyfunctional T cells that mediate rejection of murine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Tumor stroma and regulation of cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Distinct effects of leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphatidylinositol 3-kinase gamma inhibition ameliorates inflammation and tumor growth in a model of colitis-associated cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Neutralizing tumor-promoting chronic inflammation: a magic bullet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3-kinase γ promotes Rap1a-mediated activation of myeloid cell integrin α4β1, leading to tumor inflammation and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3Kγ Modulates the Cardiac Response to Chronic Pressure Overload by Distinct Kinase-Dependent and -Independent Effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Tumor angiogenesis: molecular pathways and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Myeloid cell trafficking and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3'-kinase activation and endothelial cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Class 1A PI3K regulates vessel integrity during development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Deficiency in the p110alpha subunit of PI3K results in diminished Tie2 expression and Tie2(-/-)-like vascular defects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphatidylinositol-3-kinase-gamma is integral to homing functions of progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphoinositide 3-kinase gamma gene knockout impairs postischemic neovascularization and endothelial progenitor cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Extracellular matrix degradation and remodeling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Coevolution of cancer and stromal cellular responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Cancer associated fibroblasts (CAFs) in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Accessories to the crime: functions of cells recruited to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: Association with MMP-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Oncogenic PI3K mutations lead to NF-κB-dependent cytokine expression following growth factor deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Extracellular matrix regulation of metabolism and implications for tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Inhibition of PI3K/mTOR leads to adaptive resistance in matrix-attached cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Regulation of cancer cell survival, migration, and invasion by Twist: AKT2 comes to interplay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Mesenchymal stem cell signaling in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Reduced expression of PTEN protein and its prognostic implications in invasive ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Oncogenic mutations of PIK3CA in human cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265

Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.265